Clinical Trial Update: Effect of Nicotinamide in Friedreich's Ataxia [Phase 2]

View source ↗

Summary

Nicotinamide is being studied in a Phase 2 trial for Friedreich's ataxia, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Imperial College London | Conditions: Neurodegenerative Disorders | Phase 2 | Status: UNKNOWN